assessing the role of miasm in choosing the correct remedy for the management of cases of generalized anxiety disorder

An Assessment of role of miasm (psora) in management of cases of generalized anxiety disorder

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035796

Enrollment

Registered

2021-08-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

Intervention1: Homoeopathic similimum: Potentized Homoeopathic medicine Dose-200 or 1M OR 10 M Potency Frequency- weekly. daily, monthly depending on case route of administration- oral duration of the

Eligibility

Inclusion criteria

Inclusion criteria: 1.newly diagnosed generalized anxiety disorder 2.patient opting for homoeopathic treatment for chronic illness 3.patient complying for regular follow up 4.patient who have written the consent form 5.patient of both sexes

Exclusion criteria

Exclusion criteria: 1.patients undertaking any other treatment along with homoeopathic mode of treatment 2.patient who have not written the consent form

Design outcomes

Primary

Measure	Time frame
improvement in generalized anxiety disorder 7 scale before and after the interventionTimepoint: At baseline, 2 weeks or 4 weeks or 8 weeks or 12 weeks depending on case	—

Secondary

Measure	Time frame
improvement in quality of life before and after the treatmentTimepoint: At baseline, 2 weeks or 4 weeks or 8 weeks or 12 weeks depending on case	—

Countries

India

Contacts

Public ContactDr Vinodini Patil

Bharti vidyapeeth homoeopathic medical college and hospital

drvinodinipatil@gmail.com9890127840

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026